Presbia PLC (NASDAQ:LENS) – Equities research analysts at Jefferies Group reduced their Q3 2016 earnings per share (EPS) estimates for shares of Presbia PLC in a report issued on Monday. Jefferies Group analyst R. Denhoy now anticipates that the brokerage will post earnings of ($0.29) per share for the quarter, down from their previous estimate of ($0.26). Jefferies Group has a “Market Outperform” rating on the stock. Jefferies Group also issued estimates for Presbia PLC’s Q4 2016 earnings at ($0.29) EPS, FY2016 earnings at ($1.15) EPS, FY2017 earnings at ($0.69) EPS and FY2018 earnings at ($0.40) EPS.

Several other brokerages have also weighed in on LENS. TheStreet upgraded shares of Presbia PLC from a “sell” rating to a “hold” rating in a report on Monday, July 25th. Zacks Investment Research lowered shares of Presbia PLC from a “buy” rating to a “hold” rating in a report on Wednesday, July 13th. Finally, Rodman & Renshaw set a $14.00 price objective on shares of Presbia PLC and gave the stock a “buy” rating in a report on Thursday, July 21st.

Presbia PLC (NASDAQ:LENS) remained flat at $4.50 during trading on Thursday. The stock had a trading volume of 60 shares. Presbia PLC has a one year low of $2.94 and a one year high of $6.89. The company has a 50-day moving average price of $4.41 and a 200 day moving average price of $4.53. The firm’s market cap is $60.02 million.

About Presbia PLC

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States.

5 Day Chart for NASDAQ:LENS

Receive News & Stock Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related stocks with our FREE daily email newsletter.